Danielle Balthazor, APRN
Nurse Practitioner · Topeka, KSNPI 1154851186
Payments from drug & device makers
Across 60 payments — averaging $13.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$150
- Novo Nordisk$126
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$86
- Astellas Pharma US Inc$72
- Biohaven Pharmaceuticals, Inc.$54
- Boehringer Ingelheim$37
- plus $314 from 14 others
What the payments were for
- Food & beverage$838100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $150 |
| Novo Nordisk | 9 | $126 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $86 |
| Astellas Pharma US Inc | 5 | $72 |
| Biohaven Pharmaceuticals, Inc. | 3 | $54 |
| Boehringer Ingelheim | 3 | $37 |
| AstraZeneca | 3 | $34 |
| Amgen | 2 | $34 |
| Eisai Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Johnson & Johnson | 2 | $24 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Clarus Therapeutics Inc. | 2 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| GSK | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Pfizer | 1 | $11 |
How this compares
$838 in reported general payments places this provider in the 70th percentile of 1,326 nurse practitioner providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 14 | $349 |
| Doxycycline Hyclate | 18 | $194 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $62 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Topeka
- Gary GrafTopeka$726K
- Shannon GreggTopeka$140K
- Kelli BradburyTopeka$20K
- Laura WelbornTopeka$8K
- Alexandra HeerenTopeka$8K
- Amie WunderTopeka$8K
- Jayda RuppTopeka$7K
- Lora UtechTopeka$6K
- Sarah FitzmauriceKansas City$247K
- Anna ShortRoeland Park$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.